IV-23
IV-23 (Compound 20) is a potent Noxa mediated apoptosis inducer, and it is a promising anticancer agent with potential. IV-23 inhibits cell growths in vitro and in vivo, reduces colony formation, arrests cell cycle at M phase, and induces esophageal squamous cell carcinoma (ESCC).
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 2326007-49-0
- Fòrmula: C18H18BrNO4
- Peso molecular:392.24
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
Descripciòn
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | IC50 |
6.82 μM
Compound: 9d
|
Antiproliferative activity against human A549 cells incubated for 48 hrs by CCK8 assay
Antiproliferative activity against human A549 cells incubated for 48 hrs by CCK8 assay
|
[PMID: 33965530] |
| A549 | IC50 |
6.82 μM
Compound: 9d
|
Antiproliferative activity against human A549 cells assessed as inhibition of cell proliferation measured after 48 hrs by CCK8 assay
Antiproliferative activity against human A549 cells assessed as inhibition of cell proliferation measured after 48 hrs by CCK8 assay
|
[PMID: 34022412] |
| ECa-109 cell line | IC50 |
2.24 μM
Compound: 9d
|
Antiproliferative activity against human Eca-109 cells incubated for 48 hrs by CCK8 assay
Antiproliferative activity against human Eca-109 cells incubated for 48 hrs by CCK8 assay
|
[PMID: 33965530] |
| ECa-109 cell line | IC50 |
2.24 μM
Compound: 9d
|
Antiproliferative activity against human Eca-109 cells assessed as inhibition of cell proliferation measured after 48 hrs by CCK8 assay
Antiproliferative activity against human Eca-109 cells assessed as inhibition of cell proliferation measured after 48 hrs by CCK8 assay
|
[PMID: 34022412] |
| KYSE-30 | IC50 |
1.61 μM
Compound: 9d
|
Antiproliferative activity against human KYSE-30 cells incubated for 48 hrs by CCK8 assay
Antiproliferative activity against human KYSE-30 cells incubated for 48 hrs by CCK8 assay
|
[PMID: 33965530] |
| KYSE-30 | IC50 |
1.61 μM
Compound: 9d
|
Antiproliferative activity against human KYSE-30 cells assessed as inhibition of cell proliferation measured after 48 hrs by CCK8 assay
Antiproliferative activity against human KYSE-30 cells assessed as inhibition of cell proliferation measured after 48 hrs by CCK8 assay
|
[PMID: 34022412] |
| KYSE-450 | IC50 |
1.49 μM
Compound: 9d
|
Antiproliferative activity against human KYSE-450 cells incubated for 48 hrs by CCK8 assay
Antiproliferative activity against human KYSE-450 cells incubated for 48 hrs by CCK8 assay
|
[PMID: 33965530] |
| KYSE-450 | IC50 |
1.49 μM
Compound: 9d
|
Antiproliferative activity against human KYSE-450 cells assessed as inhibition of cell proliferation measured after 48 hrs by CCK8 assay
Antiproliferative activity against human KYSE-450 cells assessed as inhibition of cell proliferation measured after 48 hrs by CCK8 assay
|
[PMID: 34022412] |
| KYSE-510 | IC50 |
2.08 μM
Compound: 9d
|
Antiproliferative activity against human KYSE-510 cells incubated for 48 hrs by CCK8 assay
Antiproliferative activity against human KYSE-510 cells incubated for 48 hrs by CCK8 assay
|
[PMID: 33965530] |
| KYSE-510 | IC50 |
2.08 μM
Compound: 9d
|
Antiproliferative activity against human KYSE-510 cells assessed as inhibition of cell proliferation measured after 48 hrs by CCK8 assay
Antiproliferative activity against human KYSE-510 cells assessed as inhibition of cell proliferation measured after 48 hrs by CCK8 assay
|
[PMID: 34022412] |
| MGC-803 | IC50 |
1.84 μM
Compound: 9d
|
Antiproliferative activity against human MGC-803 cells incubated for 48 hrs by CCK8 assay
Antiproliferative activity against human MGC-803 cells incubated for 48 hrs by CCK8 assay
|
[PMID: 33965530] |
| MGC-803 | IC50 |
1.84 μM
Compound: 9d
|
Antiproliferative activity against human MGC-803 cells assessed as inhibition of cell proliferation measured after 48 hrs by CCK8 assay
Antiproliferative activity against human MGC-803 cells assessed as inhibition of cell proliferation measured after 48 hrs by CCK8 assay
|
[PMID: 34022412] |
In Vitro
IV-23 (Compound 20) shows a strong inhibition against the ESCCs in a concentration depend manner, the IC50 values against the Kyse30 and Kyse450 cell lines were all less than 2 μM, presented in a dose-dependent manner. IV-23 triggeres caspases related apoptosis in ESCC cells[1].
IV-23 induces G2/M phase arrest[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
- Detection of Apoptosis
- TUNEL staining for apoptotic DNA fragmentation
- Flow cytometric DNA-content cell-cycle staining
- Annexin V plus membrane-impermeant dye apoptosis staining
- BrdU Incorporation Assay
- Apoptosis Solutions
- Protocol for Cell Cycle
- Soft Agar Colony Formation Assay
- Colony Formation (Clonogenic) Assay
Chemical Information
-
No. CAS 2326007-49-0
-
Peso molecular 392.24
-
Fòrmula C18H18BrNO4
-
SMILES
O=C(N1CCC2=C1C=CC(Br)=C2)C3=CC(OC)=C(OC)C(OC)=C3
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)